Michael Botticelli

Learn More
BACKGROUND Opioid addiction is a chronic disease treatable in primary care settings with buprenorphine hydrochloride, but this treatment remains underused. We describe a collaborative care model for managing opioid addiction with buprenorphine hydrochloride-naloxone hydrochloride dihydrate sublingual tablets. METHODS Ours is a cohort study of patients(More)
ii Prepared by the National Association of State Alcohol and Drug Abuse Directors (NASADAD), with support from the Substance Abuse and Mental Health Services Administration's Center for Substance Abuse Treatment under contract HHHSS283200700711TK01I/HHS28300001T, task order 283‐07‐0029, to Synergy Enterprises, Inc. NASADAD is solely responsible for the(More)
  • 1